AdventHealth Davos Alzheimer’s Collaborative study

  • days left to enroll
Updated on 19 October 2022
Recruitment Department
Primary Contact
AdventHealth Translational Research Institute (online study) Contact
cognitive impairment
cognitive decline
Online studies
Accepts healthy volunteers


The AdventHealth Research Institute has joined forces with global partners to revolutionize Alzheimer’s care through the Davos Alzheimer’s Collaborative study. By using simple memory and blood tests, our scientists will look to determine early markers of the disease.
Study goals:
• To detect biomarkers that indicate your risk for developing Alzheimer’s
• To allow for early intervention that could slow cognitive decline
• To change the future of Alzheimer’s care by creating systems that will make these assessments part of routine health exams
If you’re 65 years of age or older and have not been diagnosed with a previous cognitive impairment, you may qualify to be part of this groundbreaking study that could improve early detection and delay decline in millions of people around the world.
Visit to check eligibility.


This research involves two parts.
Part 1 - The first part involves taking a 10 -15-minute memory test online. Once you complete the online assessment, we’ll determine if you meet eligibility for the second part of this study.
Part 2- If you do meet the requirements, you’ll be invited to participate in the second part of the study, which takes place in person at the research site. At the Translational Research Institute, you will have a blood draw and complete a cognitive test. If you choose to participate in this part of the study, you will be given a separate written consent and will be compensated for your time and effort. The second part of the study consists of one visit and a possible follow up visit at 6 months.

Condition Alzheimer's Disease, Mild Cognitive Impairment
Clinical Study IdentifierTX302512
Last Modified on19 October 2022


Yes No Not Sure

Inclusion Criteria

If you’re 65 years of age or older and have not been diagnosed with dementia, you may qualify to be part of the groundbreaking study

Exclusion Criteria

If you have been diagnosed with dementia you are not be eligible to participate in this study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note